NEDD9 and endometrial cancer: Taken together, our results suggest a crucial role for ARF6 and NEDD9 as regulators of invasion in endometrial cancer through alteration of MT1-MMP activity, thus delineating an additional signaling pathway for targeting ARF6 and NEDD9 supported invasion.